| Stephen Okiye, MD | |
|
9149 Estate Thomas, Paragon Building Suite 307, St Thomas, VI 00802-2687 | |
| (340) 116-7714 | |
| (340) 777-4499 |
| Full Name | Stephen Okiye |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 9149 Estate Thomas, St Thomas, Virgin Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881799898 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 684 (Virgin Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stephen Okiye, MD #9149 Estate Thomas, Paragon Medical Building Suite 307, St Thomas, VI 00802 Ph: () - | Stephen Okiye, MD 9149 Estate Thomas, Paragon Building Suite 307, St Thomas, VI 00802-2687 Ph: (340) 116-7714 |
News Archive
Recurrent low-grade serous carcinoma, a rare type of ovarian cancer, is less sensitive to chemotherapy and therefore more difficult to treat than more common high-grade ovarian cancers, according to researchers from The University of Texas M. D. Anderson Cancer Center.
President Barack Obama opened the private session by asking all parties to look for common ground, but the entrenched positions in play will make that difficult to achieve. Senate Minority Leader Mitch McConnell, R-Ky., for instance, laid out specific conditions that must be met in order to gain GOP support. These included immediate budget caps on discretionary spending followed by eligibility changes to Medicare and Medicaid.
Manufacturers of flu vaccines are nearly ready with the new supply of vaccinations for this upcoming flu season in the northern hemisphere. Two weeks ago, five vaccine manufacturers announced plans to make between 166 million and 173 million doses for the coming season. That's at least 6 million more than the maximum ever produced. However they add that many might not actually need the shots.
BioDelivery Sciences International, Inc. announced the approval by the U.S. Food and Drug Administration of a Supplemental New Drug Application (sNDA) for a new formulation of ONSOLIS (fentanyl buccal soluble film) CII for the management of breakthrough pain in patients with cancer who are opioid tolerant.
› Verified 7 days ago
Dr. Joseph Minder, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 9048 Sugar Est, St Thomas, VI 00802 Phone: 340-776-8311 Fax: 888-300-8247 | |
John Roland Franklin, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 9003 Havensight, Suite 301, St Thomas, VI 00802 Phone: 340-774-9655 Fax: 340-774-9646 |